-Wound & Tissue Care industry associations
-Product managers, Wound & Tissue Care industry administrator, C-level executives of the industries
-Market Research and consulting firms
Key questions answered in the report
What will the market size and growth rate be in 2026?
What segment or region will drive or lead market growth and what are the reasons?
How will market drivers, constraints and future opportunities affect market dynamics and subsequent analysis of relevant trends?
What key strategies are used by top vendors to increase revenue?
About Global Market Monitor
Global Market Monitor is a professional modern consulting company, engaged in three major business categories such as market research services, business advisory, technology consulting.
Search jobs 27-Apr-2021 Wound Healing Market Detailed Analysis Of Current Industry Figures With Forecasts to 2028 By Major industry Players: IonMed Ltd.; Smith & Nephew plc; Acelity L.P. Inc.; Mölnlycke Health Care AB; Ethicon, Inc.; Convatec Group Plc; Baxter
Data Bridge Market Research announces the addition of new research analysis to the wide international database
Wound Healing Market to offer insightful views over the forecast period of 2020 – 2027. This Wound Healing report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current Industry Trends. It also reveals technological advancements, methods, and different initiatives that have a significant impact on the global Wound Healing market.
ACell Announces CE Mark Approval
Milestone Paves the Way for MicroMatrix and Cytal Wound Management Devices in European Union
News provided by
Share this article
Share this article
COLUMBIA, Md., Dec. 22, 2020 /PRNewswire/ ACell, Inc., a leading regenerative medicine company, announced today that it has received CE mark approval for its MicroMatrix®, Cytal® Wound Matrix, and Cytal® Burn Matrix devices. This regulatory approval allows ACell to distribute these products throughout the 27 countries of the European Union.
President and CEO Patrick McBrayer said, The CE Mark approval is a significant accomplishment for ACell, which required rigorous regulatory review against stringent safety and clinical standards. We are proud to be one step further to offering our wound management products to patients and their health care providers throughout Europe.
Global Bioengineered Skin Substitutes Market to Reach $4.33 Billion by 2030
The bioengineered skin substitutes market is currently at a blooming phase, with the presence of various juggernauts such as AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering a wide range of bioengineered skin substitutes products in the market. Several companies are attempting to enter the market and sustain themselves in the competition by adopting different strategies varying from partnerships and collaborations to business expansions and product launches.
Technological advancements in wound biologics coupled with innovations in the field of tissue engineering have led to the development of advanced wound healing options and strategies, including bioengineered skin substitutes. These products are being designed to treat a wide range of acute and chronic wounds that pose a serious healthcare threat g